Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling
- Resource Type
- Journal
- Source
CLINICAL SCIENCE ; APR 2020, 134 7, p695-p710, 16p.- Subject
- Language
- English
- ISSN
- 14708736